PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS
The complexity of therapy of lipid metabolism disorders is not only in comorbidity and polypragmasia, but also in predicting a genetically determined response to the treatment. The aim of our work was to study the pharmacogenetics features of pharmacotherapy of patients with non-alcoholic fatty liv...
Saved in:
Main Authors: | A. L. Khokhlov (Author), A. N. Yavorsky (Author), N. O. Pozdnyakov (Author), J. V. Rybachkova (Author), E. S. Emelianov (Author), A. A. Khokhlov (Author), A. E. Miroshnikov (Author), S. O. Pozdnyakov (Author) |
---|---|
Format: | Book |
Published: |
SINAPS LLC,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD
by: A. L. Khokhlov, et al.
Published: (2016) -
The use of a new oral antiviral drug molnupiravir in the treatment of COVID-19 from a safety perspective
by: A. L. Khokhlov, et al.
Published: (2022) -
Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl
by: A. L. Khokhlov, et al.
Published: (2023) -
Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration
by: A. L. Khokhlov, et al.
Published: (2023) -
Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19
by: O. V. Zhukova, et al.
Published: (2021)